Delivery of stimulants through an inhalation route
First Claim
1. An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of ephedrine or fenfluramine.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to the delivery of stimulants through an inhalation route. Specifically, it relates to aerosols containing ephedrine or fenfluramine that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent by weight of ephedrine or fenfluramine. In a method aspect of the present invention, one of ephedrine or fenfluramine is delivered to a mammal through an inhalation route. The method comprises: a) heating a composition, wherein the composition comprises at least 5 percent by weight of ephedrine or fenfluramine, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles, which is inhaled by the mammal. In a kit aspect of the present invention, a kit for delivering ephedrine or fenfluramine through an inhalation route to a mammal is provided which comprises: a) a composition comprising at least 5 percent by weight of ephedrine or fenfluramine; and, b) a device that forms an ephedrine or fenfluramine containing aerosol from the composition, for inhalation by the mammal.
-
Citations
14 Claims
- 1. An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of ephedrine or fenfluramine.
-
7. A method of delivering ephedrine or fenfluramine to a mammal through an inhalation route, wherein the route comprises:
-
a) heating a composition, wherein the composition comprises at least 5 percent by weight of ephedrine or fenfluramine, to form a vapor; and
,b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles, which is inhaled by the mammal. - View Dependent Claims (8, 9, 10, 11, 12, 13)
-
-
14. A kit for delivering ephedrine or fenfluramine through an inhalation route to a mammal, wherein the kit comprises:
-
a) a composition comprising at least 5 percent by weight of ephedrine or fenfluramine; and
,b) a device that forms an ephedrine or fenfluramine aerosol from the composition, for inhalation by the mammal and wherein the device comprises;
a) an element for heating the ephedrine or fenfluramine composition to form a vapor;
b) an element allowing the vapor to cool to form an aerosol; and
,c) an element permitting the mammal to inhale the aerosol.
-
Specification